Previously, AAV-mediated gene transfers of LDLR and VLDLR in mouse models of FH have produced significant decreases in serum cholesterol levels and translated also to reductions in the extent of atherosclerosis11,12,14. The gene discussed is VLDLR; the disease is familial hyperaldosteronism.